Economic impact report examines the value of open biodata infrastructure
EMBL-EBI enables global productivity gains worth £11.8bn per year and powers AI-driven science and innovation at scale.
EMBL ANNOUNCEMENTS2026
announcementsembl-announcements
AI model forecasts disease risk decades in advance
New AI model can estimate the long-term risk of over 1,000 diseases and forecast human health changes over a decade in advance.
SCIENCE & TECHNOLOGY2025
research-highlightsscience-technology
Changes in EMBL leadership
Peer Bork and Ewan Birney take up interim leadership of EMBL as Edith Heard steps down as Director General.
EMBL ANNOUNCEMENTS2025
embl-announcements
EMBL announces interim leadership
EMBL announces that Peer Bork and Ewan Birney will lead the organisation after the departure of Director General Edith Heard in summer 2025.
EMBL ANNOUNCEMENTS2024
embl-announcements
The EMBL evolution: Ewan Birney on open data and the ethos of excellence
Ewan Birney reflects on his time at EMBL and the development of the organisation through a commitment to open data and nurturing scientific talent.
PEOPLE & PERSPECTIVES2024
people-perspectivesperspectives
Reducing the carbon footprint of scientific computing
As science increasingly relies on big data and AI tools, the carbon footprint of computational work is on the rise
2023
perspectives
AI at EMBL: enabling responsible innovations in the life sciences
EMBL stands as a leader, exemplifying how to harmoniously integrate AI in research and through its delivery of data services.
LAB MATTERSPEOPLE & PERSPECTIVES2023
lab-matterspeople-perspectives
The Human Genome Project at 20: interview with Ewan Birney
On the 20th anniversary of the Human Genome Project, we look back at its history, wonder and potential.
LAB MATTERSPEOPLE & PERSPECTIVES2023
lab-matterspeople-perspectivesperspectives
Human genome editing: regulations, risks, and ethical considerations
Scientists have the technology to edit the human genome. But when should they, and who contributes to these decisions?
LAB MATTERSPEOPLE & PERSPECTIVES2023
lab-matterspeople-perspectivesperspectives
Large-scale study enables new insights into rare eye disorders
EMBL-EBI researchers use UK Biobank data to uncover new information about rare diseases of the eye.
2023
research-highlightsscience
AlphaFold: where will the next AI breakthrough come from?
Ewan Birney, Deputy Director General of EMBL and Director of EMBL-EBI, reveals the key factors that enabled AlphaFold to change the world of biology.
PEOPLE & PERSPECTIVES2022
people-perspectivesperspectivesscience
CNest: a new method for copy number variation analysis
A new method for the robust analysis of copy number variation and used UK Biobank data to identify links between genome and disease.
SCIENCE & TECHNOLOGY2022
research-highlightssciencescience-technology
Greater than the sum of our genes: DNA does not define us
Ewan Birney discusses the input of both genetics and our environment in making us who we are
LAB MATTERS2022
lab-mattersperspectives
No results found